hydralazine hydrochloride
hydralazine hydrochloride is listed in the FDA National Drug Code directory with 15 NDC codes, marketed under brand name including HYDRALAZINE HYDROCHLORIDE. Available dosage forms: tablet, tablet, film coated.
Drug Details
- Generic Name
- hydralazine hydrochloride
- Brand Names
- HYDRALAZINE HYDROCHLORIDE
- Application Number
- ANDA203845
- Sponsor
- Cadila Pharmaceuticals Limited
- NDC Codes
- 15
- Dosage Forms
- TABLET, TABLET, FILM COATED
- Routes
- ORAL
- Active Ingredients
- HYDRALAZINE HYDROCHLORIDE
Indications and Usage
INDICATIONS & USAGE Essential hypertension, alone or as an adjunct.
Warnings
WARNINGS In a few patients hydrALAZINE may produce a clinical picture simulating systemic lupus erythematosus including glomerulonephritis. In such patients hydrALAZINE should be discontinued unless the benefit-to-risk determination requires continued antihypertensive therapy with this drug. Symptoms and signs usually regress when the drug is discontinued but residua have been detected many years later. Long-term treatment with steroids may be necessary. (See PRECAUTIONS, Laboratory Tests.)